Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
5.10
-0.21 (-3.95%)
Mar 9, 2026, 2:41 PM EDT - Market open
Profound Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -42.57 | -27.82 | -28.32 | -28.67 | -30.7 | Upgrade
|
| Depreciation & Amortization | 0.56 | 0.94 | 0.93 | 1 | 1.01 | Upgrade
|
| Other Amortization | - | - | - | 0.6 | 0.87 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 2.52 | - | Upgrade
|
| Stock-Based Compensation | 5.49 | 2.58 | 3.42 | 4.24 | 7.21 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -0.31 | 0.15 | - | - | Upgrade
|
| Other Operating Activities | 0.03 | 0.56 | 0.68 | 0.13 | 0.13 | Upgrade
|
| Change in Accounts Receivable | -0.17 | 0.19 | -0.96 | -1.42 | 2 | Upgrade
|
| Change in Inventory | -2.82 | 0.66 | 0.35 | -1.86 | -2.49 | Upgrade
|
| Change in Accounts Payable | 0.38 | 0.82 | 1.35 | -0.57 | -0.36 | Upgrade
|
| Change in Unearned Revenue | 0.37 | -0.95 | 0.19 | - | - | Upgrade
|
| Change in Income Taxes | 0.04 | - | -0.3 | 0.31 | -0.01 | Upgrade
|
| Change in Other Net Operating Assets | 0.46 | 0.03 | -0.16 | -2.09 | -0.01 | Upgrade
|
| Operating Cash Flow | -38.21 | -23.45 | -22.61 | -25.8 | -22.36 | Upgrade
|
| Capital Expenditures | -0.18 | - | - | - | -0.03 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.07 | - | - | - | -0.56 | Upgrade
|
| Investing Cash Flow | -0.24 | - | - | - | -0.59 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 7.27 | - | Upgrade
|
| Total Debt Issued | - | - | - | 7.27 | - | Upgrade
|
| Long-Term Debt Repaid | -0.29 | -2.56 | -0.91 | -0.36 | -0.39 | Upgrade
|
| Total Debt Repaid | -0.29 | -2.56 | -0.91 | -0.36 | -0.39 | Upgrade
|
| Net Debt Issued (Repaid) | -0.29 | -2.56 | -0.91 | 6.92 | -0.39 | Upgrade
|
| Issuance of Common Stock | 42.44 | 62.15 | 2.67 | 0.26 | 6.43 | Upgrade
|
| Other Financing Activities | -1.02 | -4.9 | - | -0.15 | -0.1 | Upgrade
|
| Financing Cash Flow | 41.14 | 54.7 | 1.76 | 7.03 | 5.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.12 | -2.54 | 0.55 | -1.87 | 0.24 | Upgrade
|
| Net Cash Flow | 4.81 | 28.7 | -20.3 | -20.64 | -16.76 | Upgrade
|
| Free Cash Flow | -38.38 | -23.45 | -22.61 | -25.8 | -22.39 | Upgrade
|
| Free Cash Flow Margin | -238.43% | -219.60% | -314.06% | -386.17% | -325.80% | Upgrade
|
| Free Cash Flow Per Share | -1.27 | -0.95 | -1.07 | -1.24 | -1.09 | Upgrade
|
| Levered Free Cash Flow | -20.9 | -15.05 | -13.15 | -18.78 | -7.22 | Upgrade
|
| Unlevered Free Cash Flow | -20.9 | -15.05 | -13.15 | -18.68 | -7.18 | Upgrade
|
| Change in Working Capital | -1.71 | 0.59 | 0.54 | -5.63 | -0.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.